Lead Product(s): Cellspan Esophageal Implant
Therapeutic Area: Gastroenterology
Highest Development Status: IND Enabling Product Type: Undisclosed
Partner/Sponsor/Collaborator: Not Applicable
Deal Size: Not Applicable Upfront Cash: Not Applicable
Deal Type: Not Applicable March 20, 2020
The FDA notified the Company that it removed the clinical hold and that the Company may proceed with its study.